About The Medical Condition MDL17,043
Find the definition of the medical term MDL17,043. MDL17,043 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
MDL17,043
| MDL17,043 Medical Condition |
|---|
What's The Definition Of The Medical Condition MDL17,043?
1,3-Dihydro-4-methyl-5-(4-(methylthio)benzoyl)-2H-imidazol-2-one. A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Genes, Growth Suppressor ‐ Genes that inhibit expression of the tumorigenic phenotype. They…
- Spontaneous Remissions ‐ A spontaneous diminution or abatement of the symptoms of…
- Leak Potassium Channel ‐ Potassium channels that contain two pores in tandem. They are…
- Lotrimin ‐ An imidazole derivative with a broad spectrum of antimycotic…
- Hazard Surveillance Programs ‐ The development of systems to prevent accidents, injuries, and…
- Ventral Anterior Nucleus ‐ A large group of nuclei lying between the internal medullary…
- Biomodulators ‐ Biological or synthetic agents that are capable of eliciting…
- Oxytryptophan ‐ Precursor of serotonin used as antiepileptic and…
- Gallstone ‐ Presence or formation of…
- Heterotypic Antibodies ‐ Antibodies elicited in a different species from which the antigen…